CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Amortization of Prior Service Cost (Credit)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Amortization of Prior Service Cost (Credit) of $4.00 thousand for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2021-12-25 was -$148.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2021-09-25 was -$128.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2021-06-26 was -$128.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2021-03-27 was -$128.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for fiscal 2025 was $4.00K, a 0.00% change from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for fiscal 2024 was $4.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for fiscal 2023 was -$464.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, amortization of prior service cost (credit) for fiscal 2022 was -$506.00K.
| Period end | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 3 month | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 6 month | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 9 month | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 12 month |
|---|---|---|---|---|
| 2025-12-27 | $4.00K 10-K · filed 2026-02-18 | |||
| 2024-12-28 | $4.00K 10-K · filed 2026-02-18 | |||
| 2023-12-30 | -$464.00K 10-K · filed 2026-02-18 | |||
| 2022-12-31 | -$506.00K 10-K · filed 2025-02-19 | |||
| 2021-12-25 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$276.00K derived: sum of 2 quarters · filed 2024-02-14 | -$404.00K derived: sum of 3 quarters · filed 2024-02-14 | -$531.00K 10-K · filed 2024-02-14 |
| 2021-09-25 | -$128.00K 10-Q · filed 2021-11-03 | -$256.00K derived: sum of 2 quarters · filed 2021-11-03 | -$383.00K 10-Q · filed 2021-11-03 | -$497.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | -$128.00K 10-Q · filed 2021-08-04 | -$256.00K 10-Q · filed 2021-08-04 | -$369.00K derived: sum of 3 quarters · filed 2023-02-22 | -$494.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | -$128.00K 10-Q · filed 2021-05-04 | -$241.00K derived: sum of 2 quarters · filed 2023-02-22 | -$366.00K derived: sum of 3 quarters · filed 2023-02-22 | -$492.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$238.00K derived: sum of 2 quarters · filed 2023-02-22 | -$364.00K derived: sum of 3 quarters · filed 2023-02-22 | -$489.00K 10-K · filed 2023-02-22 |
| 2020-09-26 | -$125.00K 10-Q · filed 2021-11-03 | -$251.00K derived: sum of 2 quarters · filed 2021-11-03 | -$376.00K 10-Q · filed 2021-11-03 | -$1.14M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | -$126.00K 10-Q · filed 2021-08-04 | -$251.00K 10-Q · filed 2021-08-04 | -$1.01M derived: sum of 3 quarters · filed 2022-02-16 | -$922.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | -$125.00K 10-Q · filed 2021-05-04 | -$888.00K derived: sum of 2 quarters · filed 2022-02-16 | -$796.00K derived: sum of 3 quarters · filed 2022-02-16 | -$705.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | -$763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$671.00K derived: sum of 2 quarters · filed 2022-02-16 | -$580.00K derived: sum of 3 quarters · filed 2022-02-16 | -$489.00K 10-K · filed 2022-02-16 |
| 2019-09-28 | $92.00K 10-Q · filed 2020-10-29 | $183.00K derived: sum of 2 quarters · filed 2020-10-29 | $274.00K 10-Q · filed 2020-10-29 | |
| 2019-06-29 | $91.00K 10-Q · filed 2020-08-05 | $182.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-30 | $91.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-29 | -$514.00K 10-K · filed 2021-02-17 | |||
| 2017-12-30 | -$496.00K 10-K · filed 2020-02-11 | |||
| 2016-12-31 | -$292.00K 10-K · filed 2019-02-13 | |||
| 2015-12-26 | -$581.00K 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |